Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

CPhI Worldwide

german flag

Germany to set up eHealth council to promote healthcare technology

Plans new eHealth legislation in the Autumn

- PMLiVE

Grünenthal launches pain initiatives in Europe

Launches website for patients in Spain and grants German contract to B & F Brüggemann

- PMLiVE

Eisai resubmits Fycompa to G-BA for pricing assessment

But German distribution of epilepsy drug remains on hold until reimbursement settled

Oncology drugs under AMNOG: part one

Segmentation and comparator choice - lessons for cancer drug market access in Germany

- PMLiVE

Schmittgall wins Omega contract

German agency will lead promotion of several key products

german flag

Boehringer criticises German drug price freeze

And repeats demand for update of HTA system

- PMLiVE

Serviceplan ranks top among German creative agencies

Beats Peix Healthcare Communications and Schmittgall in magazine ranking

- PMLiVE

Germany looks again at Fycompa pricing

Eisai's epilepsy drug could be re-entered onto market

german flag

BMS and AZ pull diabetes drug in Germany

Unable to agree price with health authorities

Interview: Allan Hillgrove, Boehringer

Boehringer’s head of sales and marketing on access, partnerships and China on an important year for the German pharma company

- PMLiVE

Eisai lines-up Fycompa access programme for Germany

But sales suspension for epilepsy drug will continue

- PMLiVE

The evolution of IQWiG in Germany’s drug pricing policy

Over the past ten years Germany has created a well-oiled machine designed to ensure that it gets the best deal when it comes to drug prices

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links